Team

We are a team of 30+ experts, based in Finland and the United States. Meet some of our team members.

CardioSignal Board

Leadership

  • Juuso Blomster

    CEO, Ph.D. MD Cardiologist

    Juuso Blomster (MD, PhD) is the CEO and co-founder. Dr. Blomster holds a specialist degree in cardiology and is an Adjunct Professor of Cardiology at the University of Turku, Finland. His extensive career includes several international positions in medicine and pharmaceutical industry. He was also Head Physician, Medical Assessments, and Chief Innovation Officer (Head Physician), Research Services, at Turku University Hospital.

  • Tuomas Valtonen

    COO, Co-founder

    Experienced in operations and financial management.

  • Lasse Leppakorpi

    Lasse Leppäkorpi

    OPERATIONS EXECUTIVE

    Lasse Leppäkorpi is a founder, investor, and advisor with over 20 years of experience in health technology business development and biomedical engineering. He has worked as Entrepreneur in Residence for Maki.vc in 2022, managed Apple Health Technology’s software development in 2017–2021 and was the CEO and co-founder of the health technology company Beddit until 2017. Prior to his entrepreneurship, he researched ballistocardiography, the analysis of mechanical cardiac motion at Aalto University.

  • Kristiina Santalahti

    CQO

    Leading clinical studies. 10+ years experience in population studies of cardiovascular diseases.

  • Ilkka Korhonen

    Ilkka Korhonen is the Chief Technology Officer with over 30 years’ experience in biosensors, algorithms and wearables in both international business and academia. His extensive career includes software-, technology-, and algorithm leadership positions at companies such as GE Healthcare, Meta, Firstbeat Technologies, PulseOn, Tampere University of Technology and VTT.

  • Ville Ingman

    DIRECTOR, SALES & BUSINESS INTELLIGENCE

    International business and sales expert with technical background.

Board of Directors

  • David J Kim

    David J Kim,

    David is the Managing Director of DigiTx Partners, an investment firm focused on early-stage digital health investments. He began his venture career over two decades ago at MPM Capital and has made investments in both medtech and life sciences. Over the past decade, David has turned his focus on digital health and currently serves as a board member of Embr Labs, G-Tech Medical, NeoSensory, Mightier, Rune Labs, and WellDoc and as a board observer at Figure8 and Cleerly.

    David is a graduate of the Johns Hopkins University School of Medicine (MD) and Stanford Graduate School of Business (MBA)

  • Ursula Burns

    Ursula Burns served as Chairwoman of the Board of Directors and CEO of Xerox Corporation and VEON, Ltd.

    Currently, Ms. Burns serves several public, private, and non-profit boards and counsels the United States government on key policies. She serves on the Board of Directors of Uber Technologies, Inc., Endeavor Group Holdings, Inc., ExxonMobil Corporation, and IHS Holdings. She is also a member of the Mayo Clinic and the Metropolitan Museum of Art’s Board of Trustees.

    Ms. Burns was also appointed by President Obama to lead the White House national program on Science, Technology, Engineering and Math (STEM).

  • Pauliina Martikainen

    Pauliina Martikainen is a Partner at Maki.vc, a VC firm focused on seed investments in deep tech and brand-driven companies. She splits her time between covering the Nordics and focusing on European opportunities in large markets such as Health Tech. Some of the companies she is associated with are e.g. Revela, Disior, and Pixieray.

    Prior to joining Maki.vc, Pauliina co-founded a Nordic pre-seed VC firm Wave Ventures. Before her years in venture capital, she worked in the field of marketing and communications with global brands in industries such as pharma, food, and beauty.

    Pauliina holds a M.Sc and CEMS MIM from Aalto University School of Business, and a B.Soc.Sc from the University of Helsinki.